P53 Protein Expression in Patients With Myelodysplasia Treated With Allogeneic Bone Marrow Transplantation

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2017.1225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Bone Marrow Transplantation in Pediatric Patients With Therapy-Related Myelodysplasia and Leukemia

Bone Marrow Transplantation
TransplantationHematology
1998English

Allogeneic Bone Marrow Transplantation for Patients With Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
1983English

Intractable Diseases Treated With Intra-Bone Marrow-Bone Marrow Transplantation

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2014English

Mucormycosis Associated With Deferoxamine Therapy After Allogeneic Bone Marrow Transplantation

Cancer Control
MedicineOncologyHematology
1997English

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes With Bone Marrow Fibrosis

Haematologica
Hematology
2010English

Bone Mineral Density After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Treatment of Resistant Mantle Cell Lymphoma With Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1998English

Allogeneic Bone Marrow Transplantation for Alexander’s Disease

Bone Marrow Transplantation
TransplantationHematology
1997English

Aspergillus Tracheobronchitis After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy